secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001193125-23-217039
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya appoints former Bayer Pharma CEO Dieter Weinand to board of directors
--------------------------------------------------------------------------

- Board expands to 6 members; Weinand named Class I director effective August 18, 2023.
- Weinand granted option to buy 10,000 shares at $3.43, vesting on one-year anniversary.
- He joins audit and nominating/governance committees, committees expanded to 4 members.
- Weinand is former CEO and Chairman of Bayer Pharma AG; current chairman of Replimune and others.
- Coya expects to leverage his 25+ years of pharma experience for strategic guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523217039/0001193125-23-217039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523217039/d535860d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-217039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer